• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Groove Health Lands $1.5M to Improve Medication Adherence Using Predictive Analytics

by Fred Pennic 08/08/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Groove Health

Groove Health, a Chicago, IL-based digital health startup has raised $1.6 million     to help expand its data-driven medication adherence platform for health insurance companies, hospital systems, and self-insured employers. Investors of the seed round were not disclosed.

Founded in 2016, Groove Health partners with healthcare enterprises to provide value-added analytical insights and targeted outreach programs that increase medication adherence rates in chronically-ill populations. The company’s proprietary analytics platform combines existing healthcare data with patient-generated data from its mobile app and other sources to create a comprehensive understanding of each patient’s unique adherence profile.

Groove then implements its patient engagement program, which leverages a mobile app and other forms of outreach, to influence health-positive behaviors in high-risk patients.The combined platform integrates directly into the enterprise workflow, improves the efficiency of existing care teams, and provides organizations with new methods of engaging patients.

Each year in the U.S., poor medication adherence causes 30-50% of treatment failures, 125,000 deaths, and over $100 billion of avoidable healthcare spending.  A recent study found that 26% of hospital readmissions were potentially preventable and medication-related.1 The Centers for Medicare & Medicaid Services (“CMS”) and the National Committee for Quality Assurance (“NCQA”) incorporate medication adherence measures in their Star Ratings programs, which measure health plans’ performance on important dimensions of care and service.

 

“Medication adherence is a major challenge in healthcare today, with significant implications for medical outcomes,” said Andrew Hourani, Groove Health’s Founder and CEO in a statement.  “Interestingly enough, adherence is a behavioral issue, not a medical one.  At Groove Health, our interest lies at the intersection of data analysis and behavioral psychology.  How can aggregated data help us identify the causative factors of non-adherence, and how can we influence patient behavior accordingly?” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Groove Health, Medication Adherence, Predictive Analytics

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |